Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ACXP will decline by -34.08% over the next 2 Weeks and hit $1.29 by Monday, March 23, 2026. In that time frame, ACXP's share price is expected to range between $1.14 and $1.44.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 23, 2026 | 1.14 | 1.29 | 1.44 |
| Mar 20, 2026 | 1.03 | 1.18 | 1.33 |
| Mar 19, 2026 | 1.13 | 1.27 | 1.42 |
| Mar 18, 2026 | 1.12 | 1.26 | 1.42 |
| Mar 17, 2026 | 1.22 | 1.36 | 1.53 |
| Mar 16, 2026 | 1.35 | 1.50 | 1.65 |
| Mar 13, 2026 | 1.25 | 1.39 | 1.53 |
| Mar 12, 2026 | 1.33 | 1.48 | 1.62 |
| Mar 11, 2026 | 1.32 | 1.47 | 1.63 |
| Mar 10, 2026 | 1.43 | 1.57 | 1.71 |
ACXP shares rose +44.81% in Monday, March 9, 2026's trading session, rising from a previous close of $1.35 to move at $1.96. The stock demonstrated notable intraday movement (see ACXP's key stats for a full breakdown), fluctuating between $1.37 and $2.04, a +48.91% trading range. While recent weeks have seen some volatility, ACXP has managed to secure a +17.77% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.21M shares changing hands, 2.14M more than the previous session. This amounted to $4.31M in total market activity.
Will ACXP Continue Its Downward Trend?
According to analyst ratings and projections for ACXP, Acurx Pharmaceuticals, Inc. shares are anticipated to decrease by -36.04%, potentially reaching $1.44 per share by March 23, 2026. Short-term technical indicators for ACXP currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 22 negative trading days within the past 30 sessions. Based on the ACXP stock forecast, now is not the best time to buy ACXP stock because its current trading price is +51.70% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ACXP covering social and institutional perspectives.
ACXP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ACXP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.23% to 61.50%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 41.98%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 42.88%, maintains a neutral outlook for the long term. Insights into ACXP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Acurx Pharmaceuticals Short-Term Forecasts
ACXP Forecast For Next 5 Days
Our algorithm anticipates Acurx Pharmaceuticals (ACXP) stock could hit $1.54 by Mar 17, 2026. This represents a -20.99% fall from today's price, following a -8.27% change over the past five days.
ACXP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Acurx Pharmaceuticals, Inc. (ACXP) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.35, which would mean a -30.95% decrease from the current price of $1.96. Projections for this period range from a high of $2.14 to a low of $0.82.
ACXP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Acurx Pharmaceuticals's price over the next three months point to a drop. ACXP stock is expected to peak at $3.69 on May 14, 2026 before potentially dipping to $0.00 on Jun 10, 2026. On average, ACXP is likely to trade around $1.53 in the coming 90 days.
Acurx Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Acurx Pharmaceuticals (ACXP) is expected to trade between $0.00 and $3.69 throughout 2026. This would result in an average price of $0.89, potentially offering investors a -54.48% return from current levels.
Acurx Pharmaceuticals, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Acurx Pharmaceuticals, Inc. (ACXP) is positioned to show a strong performance in March 2026. The price is predicted to move between $0.00 and $3.21, settling at an average of $1.25. This could translate to a -36.06% loss.
April 2026
Based on current market signals, Acurx Pharmaceuticals, Inc. is projected to trend april 2026. We forecast a trading range from $0.00 to $3.07, with a likely average price of $1.56. Investors could expect a potential return of -20.20%.
May 2026
Our predictive algorithms indicate Acurx Pharmaceuticals, Inc. stock may see a shift in May 2026. The expected range spans $0.00–$3.69, with an average target of $1.86. This represents a cautious outlook and a possible loss of -4.86%.
June 2026
Analyzing established trends, Acurx Pharmaceuticals, Inc. looks set to move in June 2026. Projections place the stock between $0.00 and $2.92, averaging around $0.99. This suggests a -49.36% loss from current levels.
July 2026
Market indicators suggest Acurx Pharmaceuticals, Inc. could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $2.75, with a midpoint forecast of $0.95. The stock might deliver a -51.41% loss.
August 2026
Forecasting for August 2026, models estimate that Acurx Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.30, averaging $0.25. This signals a cautious trajectory with potential returns around -87.21%.
September 2026
According to our latest forecast models, Acurx Pharmaceuticals, Inc. (ACXP) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $1.95, settling at an average of $0.26. This could translate to a -86.70% loss.
October 2026
Based on current market signals, Acurx Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $1.60, with a likely average price of $0.91. Investors could expect a potential return of -53.45%.
November 2026
Our predictive algorithms indicate Acurx Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$1.23, with an average target of $0.44. This represents a cautious outlook and a possible loss of -77.49%.
December 2026
Analyzing established trends, Acurx Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $0.45, averaging around $0.58. This suggests a -70.33% loss from current levels.
January 2027
Market indicators suggest Acurx Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.57. The stock might deliver a -70.84% loss.
February 2027
Forecasting for February 2027, models estimate that Acurx Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.54. This signals a cautious trajectory with potential returns around -72.38%.
March 2027
According to our latest forecast models, Acurx Pharmaceuticals, Inc. (ACXP) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.66. This could translate to a -66.24% loss.
ACXP's history of dividends and stock splits also plays a role in long-term investor confidence.